Trichomonas vaginalis acidic phospholipase A2: isolation and partial amino acid sequence
- First Online:
Sexually transmitted diseases are a major cause of acute disease worldwide, and trichomoniasis is the most common and curable disease, generating more than 170 million cases annually worldwide. Trichomonas vaginalis is the causal agent of trichomoniasis and has the ability to destroy in vitro cell monolayers of the vaginal mucosa, where the phospholipases A2 (PLA2) have been reported as potential virulence factors. These enzymes have been partially characterized from the subcellular fraction S30 of pathogenic T. vaginalis strains. The main objective of this study was to purify a phospholipase A2 from T. vaginalis, make a partial characterization, obtain a partial amino acid sequence, and determine its enzymatic participation as hemolytic factor causing lysis of erythrocytes. Trichomonas S30, RF30 and UFF30 sub-fractions from GT-15 strain have the capacity to hydrolyze [2-14C-PA]-PC at pH 6.0. Proteins from the UFF30 sub-fraction were separated by affinity chromatography into two eluted fractions with detectable PLA A2 activity. The EDTA-eluted fraction was analyzed by HPLC using on-line HPLC-tandem mass spectrometry and two protein peaks were observed at 8.2 and 13 kDa. Peptide sequences were identified from the proteins present in the eluted EDTA UFF30 fraction; bioinformatic analysis using Protein Link Global Server charged with T. vaginalis protein database suggests that eluted peptides correspond a putative ubiquitin protein in the 8.2 kDa fraction and a phospholipase preserved in the 13 kDa fraction. The EDTA-eluted fraction hydrolyzed [2-14C-PA]-PC lyses erythrocytes from Sprague-Dawley in a time and dose-dependent manner. The acidic hemolytic activity decreased by 84% with the addition of 100 μM of Rosenthal’s inhibitor.
KeywordsTrichomonas vaginalis amino acid sequence isolation phospholipases phospholipases A2 virulence factors
Unable to display preview. Download preview PDF.
- González-Garza M.T., Castro-Garza J., Cruz-Vega D.E., Vargas-Villarreal J., Carranza-Rosales P., Mata-Cárdenas B.D., Siller-Campos L., Said-Fernández S. 2000. Entamoeba histolytica: diminution of erythrophagocytosis, phospholipase A(2), and hemolytic activities is related to virulence impairment in longterm axenic cultures. Experimental Parasitology, 96, 116–119.PubMedCrossRefGoogle Scholar
- Heath J.P. 1981. Behaviour and pathogenicity of Trichomonas vaginalis in epithelial cell cultures: a study by light and scanning electron microscopy. British Journal of Venereal Diseases, 57106–17.Google Scholar
- Said-Fernández S., Vargas-Villarreal J., Castro-Garza J., Mata-Cárdenas B.D., Navarro-Marmolejo L., Lozano-Garza G., Martínez-Rodríguez H. 1988. PEHPS medium: an alternative for axenic cultivation of Entamoeba histolytica and E. invadens. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 249–253.PubMedCrossRefGoogle Scholar
- Skispky J.P., Barclay M. 1969. Thin-layer chromatography of lipids. In: Methods in Enzymology, Lowestein J.M. 14 ed. Academic Press, New York, 530–599.Google Scholar
- Vargas-Villarreal J., Mata-Cárdenas B.D., González-Salazar F., Lozano-Garza H.G., Cortes-Gutierrez E.I., Palacios-Corona R., Martínez-Rodríguez H.G., Ramírez-Bon E., Said-Fernández S. 2003. Trichomonas vaginalis: identification of a phospholipase A-dependent hemolytic activity in a vesicular subcellular fraction. Journal of Parasitology, 89, 105–12.PubMedCrossRefGoogle Scholar
- Vargas-Villarreal J., Mata-Cárdenas B.D., Palacios-Corona R., Gonzalez-Salazar F., Cortes-Gutierrez E.I., Martinez-Rodriguez H.G., Said-Fernández S. 2005. Trichomonas vaginalis: identification of soluble and membrane-associated phospholipase A1 and A2 activities with direct and indirect hemolytic effects. Journal of Parasitology 91, 5–11.PubMedCrossRefGoogle Scholar
- WHO — World Health Organization 2010. [homepage on the Internet]. [accessed 30 April 2011]. Available from: http://whqlibdoc.who.int/hq/2001/WHO_HIV_AIDS_2001.02.pdf.Google Scholar